Avant Bio
North America, New York, United States, New York
Description
Early stage and growth equity investment firm focused on Healthtech, Tech Bio and Life Sciences across all stages.
Investor Profile
Avant Bio has backed more than 4 startups, with 4 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in Germany, United States, Canada.
- Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).
- Led 2 rounds in the past year.
Stage Focus
- Series A (50%)
- Series B (25%)
- Seed (25%)
Country Focus
- Germany (25%)
- United States (25%)
- Canada (25%)
Industry Focus
- Biotechnology
- Health Care
- Artificial Intelligence (Ai)
- Health Diagnostics
- Market Research
- Nanotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
